AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) was downgraded to Hold from Buy with a $20 target price (versus a …
Waltham, Massachusetts headquartered AMAG Pharmaceuticals Inc.'s stock finished Tuesday's session 1.71% lower …
After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and AMAG Pharmaceuticals …
AMAG Pharmaceuticals shares have climbed 46 percent since the beginning of the year. The stock has decreased 18 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) …
Yahoo!1mon
If the stock closes at or above $20 at expiration this trade will return 4.71% or 11.02% (for comparison purposes only). AMAG closed Mar 13, 2018's trading session at $20.10. In the past year, the stock has hit a 52-week low of $11.93 …
With two of the Company's drugs awaiting FDA decision for label expansion, there could be some sharp movement in the level of its stock price in February, depending upon the outcomes. AMAG Pharma's drugs seeking label expansion are …
Stock Performance Snapshot February 16, 2018 - At Friday's closing bell, AMAG Pharma's stock advanced 3.06%, …
If the stock closes at or above $18 at expiration this trade will return 7.46% or 16.71% (for comparison purposes only). AMAG closed Mar 6, 2018's trading session at $21.14. In the past year, the stock has hit a 52-week low of $11.93 and …